AstraZeneca PLC - Change In Working Capital

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-In-Working-Capital" stands at -0.286 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2024.

AstraZeneca PLC's third quarter result of 0.835 Billion USD for the item "Change In Working Capital" represents an increase of 342.03 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 0.835 Billion USD for the item "Change In Working Capital" represents an increase of 1,936.59 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of -0.286 Billion USD for the item "Change In Working Capital" represents an increase of 73.52 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.107 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.107 Billion United States Dollars.
The 3 year change is -2.30 Billion United States Dollars.
The 5 year change is -0.497 Billion United States Dollars.
The 10 year change is -1.01 Billion United States Dollars.

The Serie's long term average value is 0.279 Billion United States Dollars. It's latest available value, on 09/30/2025, is -0.565 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2018, to it's latest available value, on 09/30/2025, is +1.28 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -4.04 Billion.